title: Vaccination strategies in patients with IBD.
abstract: Patients with IBD are at increased risk of infection, in part owing to the disease itself, but mostly because of treatment with immunosuppressive drugs. Although many of these infections are vaccine-preventable, vaccination coverage in patients with IBD is extremely low. The vaccine strategies examined in this Review are based on data that enable us to provide practical advice for clinicians. Clinical evidence indicates that vaccines do not increase the risk of relapse in patients with IBD. Live vaccines are contraindicated in immunocompromised individuals, but inactivated vaccines can be safely administered. Most patients receiving immunosuppressive therapy develop an immune response after vaccination, but response rates might differ from those of nonimmunosuppressed individuals. Therefore, vaccination status should be checked and updated upon diagnosis of IBD.
authors: Gastroenterology Unit, Hospital Universitario de La Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Diego de Léon 62, Madrid 28006, Spain. gisbert@meditex.es
authors: Javier P
authors: JP
authors: Gisbert
authors: María
authors: M
authors: Chaparro
mesh_terms: D006801:Humans; D007115:Immunization Schedule; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007239:Infections / Q000209:etiology* / Q000276:immunology; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage*
chemical_list: D007166:Immunosuppressive Agents; D014612:Vaccines